Skip to main content
. 2022 Mar 14;66(4):e02108-21. doi: 10.1128/aac.02108-21

TABLE 3.

Plasma pharmacokinetic parameters of sutezolid

Parameter Cohort 1 (300 mg)
Cohort 2 (600 mg)
Cohort 3 (1,200 mg)
Cohort 4 (1,800 mg)
n Mean SD CV% n Mean SD CV% n Mean SD CV% n Mean SD CV%
Tmax (h) 6 2.18 0.94 43.15 6 2.25 1.54 68.49 6 1.75 1.13 64.52 6 2.50 1.52 60.66
Cmax (ng/mL) 6 408 109 26.81 6 782 211 27.06 6 1,440 571 39.62 6 1,550 633 40.85
AUClast (h · ng/mL) 6 1,810 490 27.11 6 3,690 694 18.80 6 7,720 3,060 39.63 6 11,400 5,350 47.08
AUCinf (h · ng/mL) 6 1,880 482 25.56 6 3,810 686 18.01 6 8,020 3,160 39.45 5 14,100 5,880 41.66
AUCextrap (%) 6 4.43 1.90 42.90 6 3.14 1.12 35.52 6 3.80 1.64 43.17 5 7.23 6.31 87.33
λz (h−1) 6 0.175 0.0308 17.67 6 0.134 0.0585 43.59 6 0.0851 0.0194 22.83 5 0.0774 0.0442 57.13
t1/2 (h) 6 4.08 0.773 18.93 6 5.74 1.61 28.00 6 8.48 1.79 21.07 5 11.7 6.80 58.05
Tlast (h) 6 17.3 4.13 23.83 6 23.7 4.46 18.83 6 40.0 9.03 22.58 6 42.0 9.30 22.13
Clast (ng/mL) 6 13.2 1.31 9.92 6 14.0 2.45 17.53 6 23.8 11.6 48.84 6 51.2 42.0 81.99
CL/F (L/h) 6 167 38.2 22.83 6 161 27.1 16.78 6 167 54.8 32.89 5 145 55.4 38.25
Vz/F (L) 6 990 335 33.82 6 1,360 436 32.09 6 2,060 898 43.60 5 2,040 382 18.71